Скачать или смотреть This Drug Doesn't Work – But Japan Approved It Anyway

Japan just approved TPOXX (Tecovirimat). Problem is... studies show this drug doesn't work. Developed by SIGA Pharmaceuticals as a treatment for monkeypox and smallpox, animal studies appeared to show promise...

...but studies on humans have been less than impressive.

And yet, Japan approved it anyway and the FDA in the United States continues to defend its decision to buy $600M worth of TPOXX.

Citations:

Van Beusekom, M., MS (2024, December 11). Trial stops enrollment after Tpoxx fails to speed clade 2 mpox healing or pain relief. CIDRAP. Retrieved March 1, 2025, from https://www.cidrap.umn.edu/mpox/trial...

(2024, August 15). The antiviral tecovirimat is safe but did not improve clade I mpox resolution in Democratic Republic of the Congo. National Institute of Health. Retrieved March 1, 2025, from https://www.nih.gov/news-events/news-...

Cohen, J. (2025, January 17). In a ‘shocker’ decision, Japan approves mpox drug that failed in two efficacy trials. Science. Retrieved March 1, 2025, from https://www.science.org/content/artic...

#TPOXX #mokeypox #science #pharmacology #drugdevelopment